Document:

exv10w1

Exhibit 10.1

EXECUTION COPY

AMENDMENT NO. 1

Dated as of March 5, 2009

to

CREDIT AGREEMENT

Dated as of June 29, 2007

          THIS AMENDMENT NO. 1 (“Amendment”) is made as of March 5, 2009, and effective as of December
31, 2008, by and among Biogen Idec Inc., a Delaware corporation (the “Borrower”), the financial
institutions listed on the signature pages hereof and Bank of America, N.A., as Administrative
Agent (the “Administrative Agent”), under that certain Credit Agreement dated as of June 29, 2007
by and among the Borrower, the Lenders and the Administrative Agent (as amended, supplemented or
otherwise modified from time to time, the “Credit Agreement”). Capitalized terms used herein and
not otherwise defined herein shall have the respective meanings given to them in the Credit
Agreement.

          WHEREAS, the Borrower has requested that certain modifications be made to the Credit
Agreement;

          WHEREAS, the Borrower, the Lenders party hereto and the Administrative Agent have agreed to
amend the Credit Agreement on the terms and conditions set forth herein;

          NOW, THEREFORE, in consideration of the premises set forth above, the terms and conditions
contained herein, and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the Borrower, the Lenders party hereto and the Administrative Agent hereby
agree to the following amendments to the Credit Agreement.

          1. Amendments to Credit Agreement. Subject to the satisfaction of the conditions precedent
set forth in Section 2 below, the Credit Agreement is hereby amended as follows:

          (a) Section 2.03(i) of the Credit Agreement is amended to delete the phrase “for the account
of each Lender” appearing in the first sentence thereof and to replace such phrase with the phrase
“for the account of each Lender (other than any Defaulting Lender)”.

          (b) Section 2.06 of the Credit Agreement is amended by adding “except as explicitly set forth
below” at the end of the penultimate sentence thereof and adding the following at the end of such
Section:

          Notwithstanding the foregoing, the Borrower shall have the right, at any time, upon at
least three Business Days’ notice to a Defaulting Lender (with a copy to the Administrative
Agent), to terminate in whole such Lender’s Commitment on a non-ratable basis. Such
termination shall be effective, (x) with respect to such Lender’s unused Commitment, on the
date set forth in such notice, provided, however, that such date shall be no earlier than
three Business Days after receipt of such notice and (y) with respect to each Loan
outstanding to such Lender, in the case of Base Rate Loans, on the date set forth in such
notice and, in the case of Eurodollar Rate Loans, on the last day of the then current
Interest Period relating to such Loan.

 

 

Upon termination of a Lender’s Commitment pursuant to the foregoing, the Borrower will pay
or cause to be paid all principal of, and interest accrued to the date of such payment on,
Loans owing to such Lender and pay any accrued commitment fees payable to such Lender
pursuant to the provisions of Section 2.09, and all other amounts payable to such Lender
hereunder (including, but not limited to, any increased costs or other amounts owing under
Section 3.04 and any indemnification for Taxes under Section 3.01); and upon such payments,
the obligations of such Lender hereunder (including, without limitation, any obligation to
fund any amount or extend any credit thereunder) shall, by the provisions hereof, be
released and discharged; provided, however, that (i) such Lender’s rights under Sections
3.01, 3.04, 3.05, and 10.04 and other provisions of the Loan Documents which by their terms
would survive the repayments of the Loans and the termination of the Credit Agreement shall
survive such release and discharge as to matters occurring prior to such date; and (ii)
except to the extent otherwise separately agreed in writing by the Borrower and such
Lender, no claim that the Borrower may have against such Lender arising out of such
Lender’s default hereunder shall be released or impaired in any way. The aggregate amount
of the Commitments of the Lenders once reduced may not be reinstated. Upon any termination
of a Lender’s Commitment described above, the Aggregate Commitments shall be reduced by an
amount equal to the amount of the terminated Commitment, and the Applicable Percentages
shall automatically be adjusted based upon the Aggregate Commitments in effect immediately
after giving effect to such termination.

          (c) Section 2.09(a) of the Credit Agreement is amended to delete the phrase “for the account
of each Lender” appearing in the first sentence thereof and to replace such phrase with the phrase
“for the account of each Lender (other than any Defaulting Lender)”.

          (d) Section 2.09(b) of the Credit Agreement is amended to delete the phrase “for the account
of each Lender” appearing in the first sentence thereof and to replace such phrase with the phrase
“for the account of each Lender (other than any Defaulting Lender)”.

          (e) Section 2.12(a) of the Credit Agreement is amended by adding at the end of the third
sentence thereof the following proviso: “; provided, however, that if a Defaulting Lender has
failed to fund its Applicable Percentage of a specific Committed Borrowing with the result that the
outstanding principal amount of the Committed Loans are not held by the Lenders in accordance with
their Applicable Percentages, then each payment in respect of such specific Committed Borrowing
shall be distributed only to the Lenders other than such Defaulting Lender until such time as the
Committed Loans are again held by the Lenders, including such Defaulting Lender, in accordance with
their Applicable Percentages.”

          2. Condition of Effectiveness. The effectiveness of this Amendment is subject to the
conditions precedent that the Administrative Agent shall have received counterparts of this
Amendment duly executed by the Borrower, the Required Lenders (including Lehman Commercial Paper
Inc. (“Lehman”)) and the Administrative Agent, and notwithstanding anything contained herein to the
contrary, Lehman shall receive payment of all fees (including commitment fees and utilization fees)
and other amounts owing to Lehman under the Credit Agreement (including, without limitation, full
repayment of any principal and interest) accrued through the date hereof. Upon the satisfaction of
such conditions precedent, (1) this Amendment shall be deemed effective as of December 31, 2008,
(2) the entire Commitment of Lehman shall be terminated effective as of December 31, 2008, (3) the
Aggregate Commitments shall be reduced by the amount of the terminated Commitment of Lehman and the
Applicable Percentages shall automatically be adjusted based upon the Aggregate Commitments in
effect immediately after giving effect to such termination, in each case effective as of December
31, 2008.

          3. Representations and Warranties of the Borrower. The Borrower hereby represents and
warrants as follows:

2

 

          (a) This Amendment and the Credit Agreement as amended hereby constitute legal, valid and
binding obligations of the Borrower and are enforceable against the Borrower in accordance with
their terms, subject to bankruptcy, insolvency, moratorium and other laws of general application
affecting creditors and general principles of equity.

          (b) As of the date hereof and giving effect to the terms of this Amendment, (i) no Default
exists and (ii) the representations and warranties (other than the representations and warranties
contained in Section 5.05(c) and Section 5.17 of the Credit Agreement) of the Borrower set forth in
the Credit Agreement, as amended hereby, are true and correct in all material respects except to
the extent that such representations and warranties specifically refer to an earlier date, in which
case they are true and correct in all material respects as of such earlier date (and the
representations and warranties contained in subsections (a) and (b) of Section 5.05 of the Credit
Agreement shall refer to the most recent statements furnished pursuant to clauses (a) and (b),
respectively, of Section 6.01 of the Credit Agreement).

          4. Reference to and Effect on the Credit Agreement.

          (a) Upon the effectiveness hereof, each reference to the Credit Agreement in the Credit
Agreement or any other Loan Document shall mean and be a reference to the Credit Agreement as
amended hereby.

          (b) Except as specifically amended above, the Credit Agreement and all other documents,
instruments and agreements executed and/or delivered in connection therewith shall remain in full
force and effect and are hereby ratified and confirmed.

          (c) The execution, delivery and effectiveness of this Amendment shall not operate as a waiver
of any right, power or remedy of the Administrative Agent or the Lenders, nor constitute a waiver
of any provision of the Credit Agreement or any other documents, instruments and agreements
executed and/or delivered in connection therewith.

          5. Governing Law. This Amendment shall be construed in accordance with and governed by the
law of the State of New York.

          6. Headings. Section headings in this Amendment are included herein for convenience of
reference only and shall not constitute a part of this Amendment for any other purpose.

          7. Counterparts. This Amendment may be executed by one or more of the parties hereto on any
number of separate counterparts, and all of said counterparts taken together shall be deemed to
constitute one and the same instrument. Signatures delivered by facsimile or PDF shall have the
same force and effect as manual signatures delivered in person.

[Signature Pages Follow]

3

 

          IN WITNESS WHEREOF, this Amendment has been duly executed as of the day and year first above
written.

	 	 	 	 	 
	 	BIOGEN IDEC INC.,

as the Borrower

 	 
	 	By:  	/s/ Michael MacLean
 	 
	 	Name:  Michael MacLean 	 
	 	Title:  SVP, Finance 	 
	 

	 	 	 	 	 
	 	BANK OF AMERICA, N.A.,

as Administrative Agent

 	 
	 	By:  	/s/ Kevin L. Ahart
 	 
	 	Name:  Kevin L. Ahart 	 
	 	Title:  Vice President 	 
	 

	 	 	 	 	 
	 	BANK OF AMERICA, N.A.,

as L/C Issuer, Swing Line Lender and as a Lender

 	 
	 	By:  	/s/ Robert LaPorte
 	 
	 	Name:  Robert LaPorte 	 
	 	Title:  Vice President 	 
	 

	 	 	 	 	 
	 	MERRILL LYNCH BANK USA,

as a Lender

 	 
	 	By:  	/s/ Louis Alder
 	 
	 	Name:  Louis Alder 	 
	 	Title:  First Vice President 	 
	 

	 	 	 	 	 
	 	WILLIAMS STREET CREDIT CORPORATION,

as a Lender

 	 
	 	By:  	/s/ Mark Walton
 	 
	 	Name:  Mark Walton 	 
	 	Title:  Assistant Vice President 	 
	 

	 	 	 	 	 
	 	GOLDMAN SACHS CREDIT PARTNERS L.P.,

as a Co-Syndication Agent and as a Lender

 	 
	 	By:  	/s/ Andrew Caditz
 	 
	 	Name:  Andrew Caditz 	 
	 	Title:  Authorized Signatory 	 

 

 

	 	 	 	 	 

	 	 	 	 	 
	 	MORGAN STANLEY BANK,

as a Lender

 	 
	 	By:  	/s/ Melissa James
 	 
	 	Name:  Melissa James 	 
	 	Title:  Authorized Signatory 	 
	 

	 	 	 	 	 
	 	LEHMAN COMMERCIAL PAPER INC.,

as a Lender

 	 
	 	By:  	/s/ Ahuva Schwager
 	 
	 	Name:  Ahuva Schwager 	 
	 	Title:  Authorized Signatory 	 
	 

	 	 	 	 	 
	 	UBS LOAN FINANCE LLC,

as a Lender

 	 
	 	By:  	/s/ Mary E. Evans
 	 
	 	Name:  Mary E. Evans 	 
	 	Title:  Associate Director 	 
	 

	 	 	 	 	 
	 	 	 
	 	By:  	                                              /s/ Irja R. Otsa
 	 
	 	Name:  Irja R. Otsa 	 
	 	Title:  Associate DirectorEX-4.1

Exhibit 4.1

THIS SECURITY AND THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS
OF ANY STATE OR OTHER JURISDICTION IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE
SECURITIES ACT, AND, ACCORDINGLY, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED EXCEPT (1)
PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OR (2) PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE
SECURITIES LAWS OF THE STATES AND OTHER JURISDICTIONS.

AKORN, INC.

COMMON STOCK PURCHASE WARRANT

To Purchase 1,939,639 Shares of Common Stock

     THIS COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for value
received, EJ FUNDS LP, a Delaware limited partnership (the “Holder”), is entitled, upon the
terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any
time on or after April 13, 2009 (the “Initial Exercise Date”) and on or prior to the close
of business on the fifth (5th) anniversary following the Initial Exercise Date (the
“Termination Date”) but not thereafter, to subscribe for and purchase from Akorn, Inc., a
Louisiana corporation (the “Company”), up to One Million Nine Hundred Thirty Nine Thousand
Six Hundred Thirty-Nine (1,939,639) shares, subject to adjustment as set forth herein (the
“Warrant Shares”) of Common Stock, no par value per share, of the Company (the “Common
Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under
this Warrant shall be $1.11 per share, subject to adjustment hereunder. The Exercise Price and the
number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as
provided herein. Capitalized terms used and not otherwise defined herein shall have the meanings
set forth in that certain Modification, Warrant and Investor Rights Agreement (the
“Modification Agreement”), dated as of April 13, 2009, between the Company and EJ FUNDS LP.

     1. Title to Warrant. Prior to the Termination Date and subject to compliance with
applicable laws and Section 7 hereof, this Warrant and all rights hereunder are
transferable, in whole or in part, at the office or agency of the Company by the Holder in person
or by duly authorized attorney, upon surrender of this Warrant together with the Assignment Form
annexed hereto properly endorsed. The transferee shall sign an investment letter in form and
substance reasonably satisfactory to the Company.

     2. Authorization of Shares. The Company covenants that all Warrant Shares which may
be issued upon any Exercise of the purchase rights represented by this Warrant will, upon such
Exercise in accordance with the terms of this Warrant, be duly authorized, validly issued, fully
paid and nonassessable and free from all taxes, liens and charges in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue). The
Company shall at all times reserve and keep available for issue upon the Exercise of

 

 

this Warrant such number of shares of its authorized but unissued Common Stock as will be
sufficient to permit the Exercise in full of this Warrant.

     3. Exercise of Warrant.

          (a) Exercise of the purchase rights represented by this Warrant may be made at any time or
times on or after the Initial Exercise Date and on or before the Termination Date by the surrender
of this Warrant and the Notice of Exercise annexed hereto duly executed, at the office of the
Company (or such other office or agency of the Company as it may designate by notice in writing to
the registered Holder at the address of such Holder appearing on the books of the Company) to the
attention of the Chief Executive Officer or the Chief Financial Officer (the “Exercise”,
and the date of such Exercise, the “Exercise Date”). After each Exercise and upon the
occurrence of the Exercise Effectiveness Date (as hereinafter defined), the Holder shall
immediately thereafter be entitled to receive a certificate for the number of Warrant Shares so
purchased upon payment of the Exercise Price of the shares thereby purchased. Payment of the
Exercise Price may be made at the option of the Holder by (i) by wire transfer or cashier’s check
drawn on a United States bank of United States dollars or (ii) the surrender and cancellation of
Warrant Shares issuable upon such Exercise of this Warrant (i.e. on a “cashless exercise” basis),
in which event the Company shall issue to the Holder a number of shares of Common Stock computed
using the following formula:

	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Y (A - B)
	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	 Where:
	 	X =
	 	A	 	 

          X = The net number of shares of Common Stock to be issued to the Holder pursuant to the
election to exercise;

          Y = The gross number of shares of Common Stock in respect of which the election to exercise is
made;

          A = The average of the market price of one share of the Common Stock for the ten (10) Trading
Days immediately prior to the Exercise Date; and

          B = The Exercise Price.

“Market Price” shall mean the closing sale price of the Company’s Common Stock as reported
on the Nasdaq Global Market, or if not then traded on the Nasdaq Global Market, such closing sale
or bid price as reported on any exchange over which the Company’s Common Stock may then be traded,
or if not then traded over any exchange, then the market price of the Company’s Common Stock shall
be the fair market value of the Company’s Common Stock as determined in good faith by the Board of
Directors of the Company. Certificates for shares purchased hereunder shall be delivered to the
Holder (at an address in the United States specified by the Holder) within five (5) Trading Days
after the later of the Exercise Effectiveness Date and payment of the Exercise Price of the shares
thereby purchased as aforesaid or the Company shall instruct its transfer agent to register the
shares purchased hereunder in book entry form within five (5) Trading Days after the later of the
Exercise Effectiveness Date and payment of the

-2-

 

Exercise Price of the shares thereby purchased as aforesaid. This Warrant shall be deemed to have
been exercised and such certificate or certificates (or book entry shares) shall be deemed to have
been issued, and the Holder or any other person so designated to be named therein shall be deemed
to have become a holder of record of such shares for all purposes, as of the last to occur of the
Exercise Effectiveness Date, payment of the Exercise Price, and delivery of the required
documentation and all taxes required to be paid by the Holder, if any, pursuant to Section
5. For purposes of this Warrant, a “Trading Day” shall mean any day on which the
national securities exchange or the national market system of FINRA are open for trading.

          (b) If this Warrant shall have been exercised in part, the Company shall, at the time of
delivery of the certificate or certificates representing Warrant Shares, deliver to the Holder a
new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called
for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

          (c) The Holder understands that, until such time as the Registration Statement has been
declared effective or the Warrant Shares may be sold pursuant to Rule 144 under the Securities Act
without any restriction as to the number of securities as of a particular date that can then be
immediately sold, (i) the Company shall be entitled to give its transfer agent stop transfer
instructions respecting those Warrant Shares and (ii) the certificates representing any Warrants
Shares issued upon Exercise of this Warrant will bear a restrictive legend in substantially the
following form:

“THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR THE
SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. THE SECURITIES MAY NOT
BE OFFERED, SOLD OR OTHERWISE TRANSFERRED EXCEPT (1) PURSUANT TO AN
EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OR (2) PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, IN EACH CASE IN
ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS OF THE STATES AND OTHER
JURISDICTIONS, AND IN THE CASE OF A TRANSACTION EXEMPT FROM REGISTRATION,
UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY
SATISFACTORY TO IT THAT SUCH TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER
THE SECURITIES ACT AND SUCH OTHER APPLICABLE LAWS.”

          (d) Reporting and Waiting Requirements.

               (i) To the extent necessary, each of and the Company and the Holder shall file, within fifteen
(15) days after each Exercise Date, before the expiration of any relevant legal deadline, with (i)
the FTC and the Antitrust Division of the DOJ, a Notification and Report Form required under the
HSR Act with respect to the transactions contemplated pursuant to such Exercise and any
supplemental information requested in connection therewith pursuant to the HSR Act, which forms
shall specifically request early termination of the waiting period

-3-

 

prescribed by the HSR Act and (ii) any other Governmental Authority, any other filings,
reports, information and documentation required for the transactions contemplated hereby pursuant
to any other antitrust law of any other jurisdiction. The parties shall furnish to each other’s
counsel such necessary information and reasonable assistance as the other may reasonably request in
connection with its preparation of any filing or submission that is necessary under the HSR Act and
any antitrust law of any other jurisdiction. The requirements under this Section 3(d)(i)
shall be satisfied with respect to any Exercise (without the need for further action by a party)
upon the soonest to occur of: (a) the HSR Clearance Date has occurred (provided, however, that
rights obtained by the Holder pursuant to the Warrant outside the United States shall become
effective upon the HSR Clearance Date or, if any ex-U.S. governmental or regulatory approvals are
required prior to such rights becoming effective, upon the later to occur of (1) the HSR Clearance
Date and (2) the receipt of any such required approvals), or (b) determination by the parties that
such filings are unnecessary (with respect to such Exercise, the “Exercise Effectiveness
Date”). The determination of the soonest to occur of the foregoing shall be made without
taking into account the need for ex-U.S. governmental or regulatory approvals required prior to
such rights becoming effective and if, giving effect to the foregoing, subsection (a) is the
soonest to occur, then the Exercise Effectiveness Date shall be the HSR Clearance Date.

               (ii) The parties shall use their reasonable best efforts to promptly obtain any clearance
required under the HSR Act and any other antitrust law for the consummation of the Exercise and the
transactions contemplated thereby and shall keep each other apprised of the status of any
communications with, and any inquiries or requests for additional information from, the FTC and the
DOJ and other Governmental Authorities concerning such clearances and shall use reasonable best
efforts to comply promptly with any such inquiry or request; provided, however, that (a) neither
party shall be required to consent to the divestiture or other disposition of any of its or its
affiliates’ assets or those of the other party, or to agree to any modification or amendment of
this Warrant that, in the reasonable opinion of such party’s legal and/or financial counsel, would
be adverse to such party, and (b) neither party shall have any obligation to contest,
administratively or in court, any ruling, order or other action of any Governmental Authority or
private party respecting the transactions contemplated by this Warrant or to comply with any other
structure or conduct remedy or restriction or limit on operation; provided, further, however, that
the parties shall both promptly respond to the DOJ or the FTC to a request for additional
information as defined under the HSR Act.

               (iii) The parties commit to instruct their respective counsel to cooperate with each other and
use reasonable best efforts to facilitate and expedite the identification and resolution of any
such issues and, consequently, the expiration of the applicable HSR Act waiting period and the
waiting periods under any other antitrust law of any other jurisdiction, or the obtaining of
clearances thereunder (as the case may be), at the earliest practicable dates. Such efforts and
cooperation include, but are not limited to, the parties’ respective counsel undertaking (i) to
keep each other appropriately informed of communications from and to personnel of the reviewing
antitrust authority, and (ii) to confer with each other regarding appropriate contacts with and
response to personnel of said antitrust authority.

               (iv) Each Party shall be responsible for its own costs and expenses associated with any filing
under the HSR Act or the Law of any other jurisdiction.

-4-

 

               (v) Certain Terms. As used in this Section 3(d), the below terms shall have the
meanings so specified.

                    (1) “DOJ” shall mean the United States Department of Justice.

                    (2) “FTC” shall mean the United States Federal Trade Commission, or any successor
entity thereto.

                    (3) “Governmental Authority” shall mean any administrative agency, commission or other
governmental authority, body or instrumentality, federal, state, local, domestic or foreign
governmental or regulatory authority.

                    (4) “HSR Act” shall mean the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended (15 U.S.C. Section 18(a)), and the rules and regulations promulgated thereunder.

                    (5) “HSR Clearance Date” shall mean the earlier of (i) the date on which the FTC shall
notify the Company and the Holder of early termination of the applicable waiting period under the
HSR Act or (ii) the day after the date on which the applicable waiting period under the HSR Act
expires without any action by any government agency or challenged to the termination.

          (e) If within five (5) Trading Days after the later of the Exercise Effectiveness Date and
payment of the Exercise Price of the shares thereby purchased, the Company shall fail to issue and
deliver a certificate to the Holder (at an address in the United States specified by the Holder)
and register such Warrant Shares on the Company’s share register, or instruct its transfer agent to
register in book entry form the number of Warrant Shares to which the Holder is entitled or credit
the Holder’s balance account with the Depository Trust Company for the number of Warrant Shares to
which the Holder is entitled upon the Holder’s exercise hereunder, and if on or after such Trading
Day the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to
deliver in satisfaction of a sale by the Holder of Warrant Shares issuable upon such Exercise that
the Holder anticipated receiving from the Company, then the Company shall, within five (5) Trading
Days after the Holder’s request promptly honor its obligation to deliver to the Holder a
certificate or certificates representing such Warrant Shares and pay cash to the Holder in an
amount equal to the excess (if any) of the Holder’s total purchase price (including brokerage
commissions, if any) for the shares of Common Stock so purchased over the product of (A) such
number of shares of Common Stock, times (B) the closing sale price of the Common Stock on the
Trading Day immediately preceding the last possible date which the Company could have issued such
Warrant Shares to the Holder without violating this Section 3(e).

     4. No Fractional Shares or Scrip. No fractional shares or scrip representing
fractional shares shall be issued upon the Exercise of this Warrant. As to any fraction of a share
which the Holder would otherwise be entitled to purchase upon such Exercise, the Company shall pay
a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the market price of one share of the Common Stock for the ten (10) Trading Days immediately
prior to the Exercise Date of this Warrant.

-5-

 

     5. Charges, Taxes and Expenses. Issuance of certificates for Warrant Shares shall be
made without charge to the Holder for any issue or transfer tax or other incidental expense in
respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the
Company, and such certificates shall be issued in the name of the Holder or in such name or names
(provided the Holder has complied with the restrictions on transfer set forth herein) as may be
directed by the Holder; provided, however, that in the event certificates for
Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed
by the Holder; and the Company may require, as a condition thereto, the payment of a sum sufficient
to reimburse it for any transfer tax incidental thereto.

     6. Closing of Books. The Company will not close its stockholder books or records in
any manner which prevents the timely Exercise of this Warrant, pursuant to the terms hereof.

     7. Transfer, Division and Combination.

          (a) Subject to compliance with any applicable securities laws and the conditions set forth in
Sections 1 and 7(e) hereof, this Warrant and all rights hereunder are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company,
together with a written assignment of this Warrant substantially in the form attached hereto duly
executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes
payable upon the making of such transfer. Upon such surrender and, if required, such payment, the
Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or
assignees and in the denomination or denominations specified in such instrument of assignment, and
shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned,
and this Warrant shall promptly be cancelled. A Warrant, if properly assigned, may be Exercised by
a new holder for the purchase of Warrant Shares without having a new Warrant issued.

          (b) This Warrant may be divided or combined with other Warrants upon presentation hereof at
the aforesaid office of the Company, together with a written notice specifying the names and
denominations in which new Warrants are to be issued, signed by the Holder or its agent or
attorney. Subject to compliance with Section 7(a) hereof, as to any transfer which may be
involved in such division or combination, the Company shall execute and deliver a new Warrant or
Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such
notice.

          (c) The Company shall prepare, issue and deliver at its own expense (other than transfer
taxes) the new Warrant or Warrants under this Section 7.

          (d) The Company agrees to maintain, at its aforesaid office, books for the registration and
the registration of transfer of the Warrants.

          (e) Prior to, and as a condition of, any transfer of this Warrant, the Holder or transferee of
this Warrant, as the case may be must (i) execute and deliver to the Company an investment letter
in form and substance reasonably acceptable to the Company and (ii) qualify as an “accredited
investor” as defined in Rule 501(a) promulgated under the Securities Act.

-6-

 

     8. No Rights as Stockholder until Exercise. This Warrant does not entitle the Holder
to any voting rights or other rights as a stockholder of the Company prior to the Exercise hereof.
Upon the surrender of this Warrant and the payment of the aggregate Exercise Price, the Warrant
Shares so purchased shall be and be deemed to be issued to such Holder as the record owner of such
shares as of the close of business on the later of the date of such surrender or payment.

     9. Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon
receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or
mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of
loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the
case of the Warrant, shall not include the posting of any bond or letter of credit), and upon
surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will
make and deliver a new Warrant or stock certificate of like tenor and dated as of such
cancellation, in lieu of such Warrant or stock certificate.

     10. Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of
any action or the expiration of any right required or granted herein shall be a Saturday, Sunday or
a legal holiday, then such action may be taken or such right may be Exercised on the next
succeeding day not a Saturday, Sunday or legal holiday.

     11. Adjustments of Exercise Price and Number of Warrant Shares. The number and kind
of securities purchasable upon the Exercise of this Warrant and the Exercise Price shall be subject
to adjustment from time to time upon the happening of any of the following. In case the Company
shall (i) pay a dividend in shares of Common Stock or make a distribution in shares of Common Stock
to holders of its outstanding Common Stock, (ii) subdivide its outstanding shares of Common Stock
into a greater number of shares, (iii) combine its outstanding shares of Common Stock into a
smaller number of shares of Common Stock, or (iv) issue any shares of its capital stock in a
reclassification of the Common Stock, then the number of Warrant Shares purchasable upon Exercise
of this Warrant immediately prior thereto shall be adjusted so that the Holder shall be entitled to
receive the kind and number of Warrant Shares or other securities of the Company which it would
have owned or have been entitled to receive had such Warrant been exercised in advance thereof.
Upon each such adjustment of the kind and number of Warrant Shares or other securities of the
Company which are purchasable hereunder, the Holder shall thereafter be entitled to purchase the
number of Warrant Shares or other securities resulting from such adjustment at an Exercise Price
per Warrant Share or other security obtained by multiplying the Exercise Price in effect
immediately prior to such adjustment by the number of Warrant Shares purchasable pursuant hereto
immediately prior to such adjustment and dividing by the number of Warrant Shares or other
securities of the Company resulting from such adjustment. An adjustment made pursuant to this
paragraph shall become effective immediately after the effective date of such event retroactive to
the record date, if any, for such event.

     12. Reorganization, Reclassification, Merger, Consolidation or Disposition of Assets.
In case of (i) any capital reorganization or reclassification, (ii) any consolidation or merger to
which the Company is a party other than a merger or consolidation in which the Company is the
continuing corporation, (iii) any sale or conveyance to another entity of the property of the
Company as an entirety or substantially as an entirety, or (iv) any statutory exchange of
securities with another corporation (including any exchange effected in connection with a merger of
a third corporation into the Company) (each, a “Fundamental Transaction”), the Holder of
this

-7-

 

Warrant shall have the right thereafter to receive on the Exercise of this Warrant the kind
and amount of securities, cash or other property which the Holder would have owned or have been
entitled to receive immediately after such Fundamental Transaction had this Warrant been exercised
immediately prior to the effective date of such Fundamental Transaction and in any such case, if
necessary, appropriate adjustment shall be made in the application of the provisions set forth in
Section 11 hereof with respect to the rights and interests thereafter of the Holder of this
Warrant to the end that the provisions set forth in Section 11 hereof shall thereafter
correspondingly be made applicable, as nearly as may reasonably be, in relation to any shares of
stock or other securities or property thereafter deliverable on the Exercise of this Warrant. The
above provisions of this Section 12 shall similarly apply to successive Fundamental
Transactions. The Company shall require the issuer of any shares of stock or other securities or
property thereafter deliverable on the Exercise of this Warrant to be responsible for all of the
agreements and obligations of the Company hereunder. Notice of any such Fundamental Transaction
and of said provisions so proposed to be made, shall be mailed to the Holder of this Warrant not
less than thirty (30) days prior to such event. A sale of all or substantially all of the assets
of the Company for a consideration consisting primarily of securities shall be deemed a
consolidation or merger for the foregoing purposes. Notwithstanding the foregoing, following a
Fundamental Transaction in which all or substanitally all of the outstanding Common Stock of the
Company is exchanged for, converted into, acquired for or constitutes the right to receive solely
cash (a “Triggering Event”), at the written request of the Holder delivered before the
twentieth (20th) day after such Triggering Event, the Company (or the successor entity)
shall purchase this Warrant from the Holder by paying to the Holder, within five days after such
request, cash in an amount equal to the Black-Scholes Value (as defined below) of the remaining
unexercised portion of this Warrant. “Black-Scholes Value” means the value of the
unexercised portion of this Warrant calculated using the Black-Scholes Option Pricing Model
determined as of the day immediately following the public announcement of the applicable Triggering
Event and reflecting (i) a risk-free interest rate corresponding to the U.S. Treasury rate for a
period equal to the remaining term of this Warrant as of the date of such request and (ii) an
expected volatility equal to the one-hundred (100) day volatility obtained from the HVT function on
Bloomberg.

     13. Notice of Adjustment. Whenever the number of Warrant Shares or number or kind of
securities or other property purchasable upon the Exercise of this Warrant or the Exercise Price is
adjusted, as herein provided, the Company shall give notice thereof to the Holder, which notice
shall state the number of Warrant Shares (and other securities or property) purchasable upon the
Exercise of this Warrant and the Exercise Price of such Warrant Shares (and other securities or
property) after such adjustment, setting forth a brief statement of the facts requiring such
adjustment and setting forth the computation by which such adjustment was made.

     14. Notice of Distribution. If the Board of Directors of the Company shall declare
any dividend or other distribution with respect to its Common Stock other than a cash distribution
out of earned surplus, the Company shall mail notice thereof to the Holder of this Warrant not less
than twenty (20) days prior to the record date fixed for determining stockholders entitled to
participate in such dividend or other distribution. Each such written notice shall be sufficiently
given if addressed to the Holder at the last address of the Holder appearing on the books of the
Company and delivered in accordance with Section 16(d) hereof.

-8-

 

     15. Registration Rights. The Common Stock issuable upon Exercise of this Warrant
shall constitute Registrable Securities (as such term is defined in the Modification Agreement).
The original Holder of this Warrant, and any valid transferees thereof pursuant to the Modification
Agreement, shall be entitled to all of the benefits afforded to a holder of any Registrable
Securities under the Modification Agreement and such holder, by its acceptance of this Warrant,
agrees to be bound by and to comply with the terms and conditions of the Modification Agreement
applicable to the holder as a holder of Registrable Securities.

     16. Miscellaneous.

          (a) Jurisdiction. This Warrant shall constitute a contract under the laws of the
State of Louisiana.

          (b) Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the
Exercise of this Warrant, if not registered, will have restrictions upon resale imposed by state
and federal securities laws.

          (c) Nonwaiver. No course of dealing or any delay or failure to exercise any right
hereunder on the part of the Holder shall operate as a waiver of such right or otherwise prejudice
the Holder’s rights, powers or remedies, notwithstanding all rights hereunder terminate on the
Termination Date.

          (d) Notices. Any notice, request or other document required or permitted to be given
or delivered to the Holder by the Company shall be delivered in accordance with the notice
provisions of the Modification Agreement; provided, that upon any permitted assignment of
this Warrant, the assignee shall promptly provide the Company with its contact information.

          (e) Limitation of Liability. No provision hereof, in the absence of any affirmative
action by the Holder to Exercise this Warrant or purchase Warrant Shares, and no enumeration herein
of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the
purchase price of any Common Stock or as a stockholder of the Company, whether such liability is
asserted by the Company or by creditors of the Company.

          (f) Remedies. The Holder, in addition to being entitled to exercise all rights
granted by law, including recovery of damages, will be entitled to specific performance of its
rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant
and hereby agrees to waive the defense in any action for specific performance that a remedy at law
would be adequate.

          (g) Successors and Assigns. Subject to applicable securities laws, this Warrant and
the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the
successors of the Company and the successors and permitted assigns of the Holder.

          (h) Amendment. This Warrant may be modified or amended or the provisions hereof
waived with the written consent of the Company and the Holder.

-9-

 

     (i) Severability. Wherever possible, each provision of this Warrant shall be
interpreted in such manner as to be effective and valid under applicable law, but if any provision
of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be
ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of
such provisions or the remaining provisions of this Warrant.

     (j) Headings. The headings used in this Warrant are for the convenience of reference
only and shall not, for any purpose, be deemed a part of this Warrant.

* * *

-10-

 

     IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer
thereunto duly authorized.

Dated: April 13, 2009

	 	 	 	 	 
	 	AKORN, INC.

 	 
	 	By:  	/s/ Jeffrey A. Whitnell
 	 
	 	 	Name:  	Jeffrey A. Whitnell 	 
	 	 	Title:  	CFO 	 
	 

[Signature Page to Common Stock Purchase Warrant]

 

 

NOTICE OF EXERCISE

To: Akorn, Inc.

     1. The
undersigned hereby elects to purchase                                Warrant Shares of Akorn, Inc. pursuant
to the terms of the attached Warrant, and tenders herewith payment of the exercise price for such
Warrant Shares in full, together with all applicable transfer taxes, if any. Payment shall take
the form of lawful money of the United States.

     2. The undersigned hereby elects to exercise the attached Warrant into Warrant Shares of
Akorn, Inc. through “cashless exercise” in the manner specified in the Warrant. This exercise is
made with respect to
                               of the Warrant Shares covered by the Warrant.

     3. Please issue a certificate or certificates representing said Warrant Shares in the name of
the undersigned or in such other name as is specified below:

 

The Warrant Shares shall be delivered to the following:

 

 

 

     4. Accredited Investor. The undersigned is an “accredited investor” as defined in
Regulation D promulgated under the Securities Act of 1933, as amended.

	 	 	 	 	 
	 	[PURCHASER]

 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	 	Dated:	 	 

 

 

ASSIGNMENT FORM

(To assign the foregoing Warrant, execute

this form and supply required information.

Do not use this form to exercise the Warrant.)

     FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned
to                     
                    
                                                                     
                  
                   
                   
                   
                   
                   
  whose address is

.
 

 

Dated: ______________, _______

	 	 	 	 	 	 	 
	 

	 	Holder’s Signature:	 	 	 	 
	 

	 	 	 	 

	 	 
	 

	 	Holder’s Address:	 	 	 	 
	 

	 	 	 	 

	 	 
	 
	 

	 	 	 	 

	 	 

	 	 	 	 	 
	Signature Guaranteed:
	 	 	 	 
	 

	 	 

	 	 

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the
face of the Warrant, without alteration or enlargement or any change whatsoever, and must be
guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or
other representative capacity should file proper evidence of authority to assign the foregoing
Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}]]